Applied Genetic Technologies appoints CFO
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Insight Weekly: Renewables lead capacity additions; bank mergers of equals up; nickel IPOs surge
Insight Weekly: Utilities face headwinds; S&P 500 dividend hikes likely; dollar poised for rally
Biotechnology company Applied Genetic Technologies Corp. appointed William Sullivan to the position of CFO, effective Aug. 7.
Larry Bullock is retiring as CFO of the company.
Sullivan previously held several leadership positions at Merrimack Pharmaceuticals Inc., including CFO, principal accounting officer and treasurer.
